{"transactions":[{"id":4617833,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-15T20:06:19.000Z","date":"2026-09-11","kind":"grant","planned":false,"acquired":true,"shares":56328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The exercise price is reported in U.S. dollars and reflects the conversion from EUR to USD at an exchange rate of $1.1616 per EUR 1.00 as of September 10, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"33% of the shares underlying this option shall vest on September 11, 2027, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":56328,"derivative":{"exercise_price":13.94,"expiration_date":"2036-01-15","underlying":"Common shares","underlying_shares":56328},"source":{"system":"sec-edgar","filing":"0001104659-26-107915","document":"tm2625420-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000110465926107915/tm2625420-3_4seq1.xml","form_type":"4"}},{"id":755260,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-02T21:41:55.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 22,000 Common Shares, with 100% of the shares vesting on November 29, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 22,000 Common Shares, with 100% of the shares vesting on November 29, 2028."}],"balance_after":22000,"derivative":{"underlying":"Common Shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001193125-26-253926","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526253926/ownership.xml","form_type":"4"}},{"id":757358,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-01T21:35:40.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028."}],"balance_after":20000,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-251817","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526251817/ownership.xml","form_type":"4"}},{"id":757357,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-06-01T21:35:40.000Z","date":"2026-05-29","kind":"sale","planned":false,"acquired":false,"shares":3786,"price":55.62,"value":210577.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":19357,"source":{"system":"sec-edgar","filing":"0001193125-26-251817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526251817/ownership.xml","form_type":"4"}},{"id":757356,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-06-01T21:35:40.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":23143,"source":{"system":"sec-edgar","filing":"0001193125-26-251817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526251817/ownership.xml","form_type":"4"}},{"id":829534,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:36:41.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 30,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 30,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."}],"balance_after":30000,"derivative":{"underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-122267","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526122267/ownership.xml","form_type":"4"}},{"id":829533,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-24T21:36:41.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":38499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 20, 2026 with respect to 38,499 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2026."}],"balance_after":38499,"derivative":{"exercise_price":46.24,"expiration_date":"2036-03-20","underlying":"Common Shares","underlying_shares":38499},"source":{"system":"sec-edgar","filing":"0001193125-26-122267","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526122267/ownership.xml","form_type":"4"}},{"id":838575,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:37:40.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":8125,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":24375,"derivative":{"underlying":"Common Shares","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001193125-26-111286","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526111286/ownership.xml","form_type":"4"}},{"id":838574,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:40.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":3150,"price":48.26,"value":152019.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":13143,"source":{"system":"sec-edgar","filing":"0001193125-26-111286","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526111286/ownership.xml","form_type":"4"}},{"id":838573,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:40.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":8125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 592 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan."}],"balance_after":16293,"source":{"system":"sec-edgar","filing":"0001193125-26-111286","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526111286/ownership.xml","form_type":"4"}},{"id":930161,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-01-27T22:35:15.000Z","date":"2025-04-03","kind":"purchase","planned":false,"acquired":true,"shares":1508,"price":32.96,"value":49703.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase of Common Shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 1,508 shares, with a subsequent sale of Common Shares at a price of $35.94 per share on May 29, 2025 pursuant to a mandatory \"sell to cover\" provision in an award agreement covering a restricted stock unit that vested on such date (and which was reported on a separate Form 4 filing dated May 30, 2025). The Reporting Person has agreed to pay to the Issuer $4,493.84, representing the full amount of the profit realized in connection with the short-swing transaction."}],"balance_after":1508,"source":{"system":"sec-edgar","filing":"0001193125-26-024955","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526024955/ownership.xml","form_type":"4"}},{"id":1024946,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T21:37:49.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 3, 2025 with respect to 16,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025."}],"balance_after":16500,"derivative":{"exercise_price":67.74,"expiration_date":"2035-10-03","underlying":"Common Shares","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001193125-25-230508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312525230508/ownership.xml","form_type":"4"}},{"id":1125553,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-04T01:45:03.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on May 30, 2025 with respect to 25,000 Common Shares, with 100% of the shares vesting on May 30, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on May 30, 2025 with respect to 25,000 Common Shares, with 100% of the shares vesting on May 30, 2028."}],"balance_after":25000,"derivative":{"underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-25-081361","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000095017025081361/ownership.xml","form_type":"4"}},{"id":1129525,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-30T21:00:17.000Z","date":"2025-05-28","kind":"exercise","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028."}],"balance_after":30000,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-25-079822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000095017025079822/ownership.xml","form_type":"4"}},{"id":1129524,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2025-05-30T21:00:17.000Z","date":"2025-05-29","kind":"sale","planned":false,"acquired":false,"shares":3932,"price":35.94,"value":141316.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":6068,"source":{"system":"sec-edgar","filing":"0000950170-25-079822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000095017025079822/ownership.xml","form_type":"4"}},{"id":1129523,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2025-05-30T21:00:17.000Z","date":"2025-05-28","kind":"exercise","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-25-079822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000095017025079822/ownership.xml","form_type":"4"}},{"id":1200634,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-18T21:35:08.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":32500,"derivative":{"underlying":"Common Shares","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0000950170-25-041470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000095017025041470/ownership.xml","form_type":"4"}},{"id":1200633,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T21:35:08.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":46667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 14, 2025 with respect to 46,667 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025."}],"balance_after":46667,"derivative":{"exercise_price":42.12,"expiration_date":"2035-03-14","underlying":"Common Shares","underlying_shares":46667},"source":{"system":"sec-edgar","filing":"0000950170-25-041470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000095017025041470/ownership.xml","form_type":"4"}},{"id":1384252,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-18T21:35:04.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 16, 2024 with respect to 18,333 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 16, 2024."}],"balance_after":18333,"derivative":{"exercise_price":49,"expiration_date":"2034-10-16","underlying":"Common Shares","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0000950170-24-115697","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000095017024115697/ownership.xml","form_type":"4"}},{"id":1499391,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-29T20:15:03.000Z","date":"2024-05-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028."}],"balance_after":40000,"derivative":{"underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000950170-24-065943","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000095017024065943/ownership.xml","form_type":"4"}},{"id":1499390,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T20:15:03.000Z","date":"2024-05-28","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 28, 2024 with respect to 85,000 Common Shares. 25% of the shares shall vest on May 28, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":85000,"derivative":{"exercise_price":54.84,"expiration_date":"2034-05-28","underlying":"Common Shares","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000950170-24-065943","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000095017024065943/ownership.xml","form_type":"4"}}]}